Is PG's Q3 2025 guidance too optimistic?
5/7/2025 05:35pm
**Procter & Gamble's (PG) Q3 2025 guidance appears to be cautiously optimistic.** Here's an analysis to support this view:
1. **Earnings Guidance**: PG updated its FY2025 diluted net earnings per share growth guidance to be in the range of 6% to 8% versus FY2024 diluted net EPS of $6.02. This suggests a positive outlook, but the company now expects fiscal 2025 core EPS growth to be in the range of $6.72 to $6.82 per share vs $6.87 consensus, equating to two to four percent growth versus FY2024 core EPS of $6.59. This indicates a more conservative expectation within the guidance range.
2. **Organic Sales Growth Target**: PG outlined a 2% organic sales growth target for fiscal 2025, driven by innovation and market investments. This target is aligned with the company's focus on delivering superiority across its portfolio and reflects confidence in its brand growth and market penetration.
3. **Share Buyback Initiatives**: PG has been actively repurchasing shares, with 8.4 million shares bought in Q3. This initiative enhances shareholder value and suggests confidence in the company's financial health and future cash flows.
4. **Market Conditions and Headwinds**: Despite the positive guidance, PG acknowledges headwinds such as commodity cost pressures and unfavorable foreign exchange rates, which could impact margins and sales growth. The company is making adjustments to its near-term outlook to reflect these market conditions while maintaining confidence in long-term growth prospects.
5. **Historical Performance**: PG has a track record of delivering strong long-term value creation, with a total shareholder return of 60.10% over five years. This historical performance supports the notion that the company's guidance is based on a solid foundation of strategic initiatives and market positioning.
In conclusion, while PG's Q3 2025 guidance reflects a positive outlook, it is tempered by a realistic assessment of current market conditions and headwinds. The company's strategic focus on innovation, international expansion, and shareholder returns suggests that the guidance is cautiously optimistic, well-supported by its historical performance and current strategic initiatives.